1 | Case | 1.5% | |
2 | Study | 1.29% | |
3 | Report | 1.07% | |
4 | Medicina | 0.86% | |
5 | Syndrome | 0.64% | |
6 | Cancer | 0.64% | |
7 | COVID-19 | 0.64% | |
8 | FDA | 0.64% | |
9 | Toxic | 0.43% | |
10 | Colorectal | 0.43% | |
11 | Association | 0.43% | |
12 | Patients | 0.43% | |
13 | New | 0.43% | |
14 | Depression | 0.43% | |
15 | Medical | 0.43% | |
16 | Risk | 0.43% | |
17 | Dysfunction | 0.43% | |
18 | Moderna | 0.43% | |
19 | Postoperative | 0.43% | |
20 | Rare | 0.43% | |
21 | Lower | 0.43% | |
22 | Line | 0.43% | |
23 | NSCLC | 0.43% | |
24 | Covid | 0.43% | |
25 | New-Onset | 0.21% | |
26 | Real-Time | 0.21% | |
27 | Patient | 0.21% | |
28 | Framework | 0.21% | |
29 | Todas | 0.21% | |
30 | Coronavirus | 0.21% | |
31 | Nimbus. | 0.21% | |
32 | HER2-Low/Ultralow | 0.21% | |
33 | BTT | 0.21% | |
34 | 3D | 0.21% | |
35 | IMCRJ | 0.21% | |
36 | Mondiale. | 0.21% | |
37 | Bladder | 0.21% | |
38 | Prime | 0.21% | |
39 | Reduced | 0.21% | |
40 | Center | 0.21% | |
41 | Ultrasonic | 0.21% | |
42 | Free | 0.21% | |
43 | Hyperreactivity | 0.21% | |
44 | Chuvi | 0.21% | |
45 | Agonist-Associated | 0.21% | |
46 | BMC | 0.21% | |
47 | Upended | 0.21% | |
48 | Miguel | 0.21% | |
49 | Mediterranean | 0.21% | |
50 | Gyroscopic | 0.21% | |
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
US FDA approves Moderna's next-generation COVID vaccine for adults 65 or older
Reuters
2025-05-31 15:16:00
Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE
Moderna Investor Relations
2025-05-31 14:06:18